Published in Mol Syst Biol on July 28, 2009
Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol (2012) 6.38
Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol Syst Biol (2009) 2.98
Software for systems biology: from tools to integrated platforms. Nat Rev Genet (2011) 2.42
Logic-based models for the analysis of cell signaling networks. Biochemistry (2010) 2.21
Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes. Mol Cell Proteomics (2010) 1.77
CellNOptR: a flexible toolkit to train protein signaling networks to data using multiple logic formalisms. BMC Syst Biol (2012) 1.60
A comprehensive map of the mTOR signaling network. Mol Syst Biol (2010) 1.59
Training signaling pathway maps to biochemical data with constrained fuzzy logic: quantitative analysis of liver cell responses to inflammatory stimuli. PLoS Comput Biol (2011) 1.53
Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases. PLoS One (2011) 1.51
Comparing signaling networks between normal and transformed hepatocytes using discrete logical models. Cancer Res (2011) 1.45
graphite - a Bioconductor package to convert pathway topology to gene network. BMC Bioinformatics (2012) 1.44
Creating and analyzing pathway and protein interaction compendia for modelling signal transduction networks. BMC Syst Biol (2012) 1.28
Comparisons of seven algorithms for pathway analysis using the WTCCC Crohn's Disease dataset. BMC Res Notes (2011) 1.24
Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data. Front Genet (2014) 1.22
IPAD: the Integrated Pathway Analysis Database for Systematic Enrichment Analysis. BMC Bioinformatics (2012) 1.17
Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn's disease. PLoS Genet (2013) 1.14
AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease. BMC Syst Biol (2012) 1.13
Precise generation of systems biology models from KEGG pathways. BMC Syst Biol (2013) 1.11
Critical assessment of human metabolic pathway databases: a stepping stone for future integration. BMC Syst Biol (2011) 1.10
Extending biochemical databases by metabolomic surveys. J Biol Chem (2011) 1.09
A comprehensive molecular interaction map of the budding yeast cell cycle. Mol Syst Biol (2010) 1.06
Comparison of human cell signaling pathway databases--evolution, drawbacks and challenges. Database (Oxford) (2015) 1.06
The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis. Front Mol Biosci (2014) 1.04
Payao: a community platform for SBML pathway model curation. Bioinformatics (2010) 1.02
BiNoM 2.0, a Cytoscape plugin for accessing and analyzing pathways using standard systems biology formats. BMC Syst Biol (2013) 1.02
R-based software for the integration of pathway data into bioinformatic algorithms. Biology (Basel) (2014) 1.01
Qualitative translation of relations from BioPAX to SBML qual. Bioinformatics (2012) 0.98
Automatic filtering and substantiation of drug safety signals. PLoS Comput Biol (2012) 0.96
NaviCell: a web-based environment for navigation, curation and maintenance of large molecular interaction maps. BMC Syst Biol (2013) 0.96
Learning dysregulated pathways in cancers from differential variability analysis. Cancer Inform (2014) 0.94
Current perspectives on the use of alternative species in human health and ecological hazard assessments. Environ Health Perspect (2013) 0.92
Automatically visualise and analyse data on pathways using PathVisioRPC from any programming environment. BMC Bioinformatics (2015) 0.90
Network medicine analysis of COPD multimorbidities. Respir Res (2014) 0.87
Pathway Analysis: State of the Art. Front Physiol (2015) 0.86
Drug target prioritization by perturbed gene expression and network information. Sci Rep (2015) 0.85
Identification of aberrant pathways and network activities from high-throughput data. Brief Bioinform (2012) 0.85
Signalogs: orthology-based identification of novel signaling pathway components in three metazoans. PLoS One (2011) 0.85
Toward an integrated software platform for systems pharmacology. Biopharm Drug Dispos (2013) 0.85
OREMPdb: a semantic dictionary of computational pathway models. BMC Bioinformatics (2012) 0.83
Microarray analyses reveal novel targets of exercise-induced stress resistance in the dorsal raphe nucleus. Front Behav Neurosci (2013) 0.83
Fetal membrane biomarker network diversity and disease functions induced by intra-amniotic pathogens. Am J Reprod Immunol (2012) 0.82
Applications of translational bioinformatics in transplantation. Clin Pharmacol Ther (2011) 0.81
Extracting reaction networks from databases-opening Pandora's box. Brief Bioinform (2013) 0.79
Accelerating cancer systems biology research through Semantic Web technology. Wiley Interdiscip Rev Syst Biol Med (2012) 0.79
Querying quantitative logic models (Q2LM) to study intracellular signaling networks and cell-cytokine interactions. Biotechnol J (2012) 0.78
Reactome from a WikiPathways Perspective. PLoS Comput Biol (2016) 0.78
A Six-Stage Workflow for Robust Application of Systems Pharmacology. CPT Pharmacometrics Syst Pharmacol (2016) 0.77
KOMODO: a web tool for detecting and visualizing biased distribution of groups of homologous genes in monophyletic taxa. Nucleic Acids Res (2012) 0.77
Signaling hypergraphs. Trends Biotechnol (2014) 0.76
Discerning mechanistically rewired biological pathways by cumulative interaction heterogeneity statistics. Sci Rep (2015) 0.76
Bidirectional Expression of Metabolic, Structural, and Immune Pathways in Early Myopia and Hyperopia. Front Neurosci (2016) 0.75
A systems biological approach reveals multiple crosstalk mechanism between gram-positive and negative bacterial infections: an insight into core mechanism and unique molecular signatures. PLoS One (2014) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
KEGG for linking genomes to life and the environment. Nucleic Acids Res (2007) 49.37
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics (2003) 32.92
Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res (2006) 20.92
Reactome: a knowledgebase of biological pathways. Nucleic Acids Res (2005) 20.05
MINT: a Molecular INTeraction database. FEBS Lett (2002) 17.21
The universal protein resource (UniProt). Nucleic Acids Res (2007) 16.33
Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res (2008) 15.69
The Pathway Tools software. Bioinformatics (2002) 14.89
IntAct--open source resource for molecular interaction data. Nucleic Acids Res (2006) 13.82
Reactome: a knowledge base of biologic pathways and processes. Genome Biol (2007) 13.36
PID: the Pathway Interaction Database. Nucleic Acids Res (2008) 12.92
Human protein reference database--2006 update. Nucleic Acids Res (2006) 12.16
COPASI--a COmplex PAthway SImulator. Bioinformatics (2006) 10.57
EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol (2006) 10.39
WikiPathways: pathway editing for the people. PLoS Biol (2008) 8.13
Broadening the horizon--level 2.5 of the HUPO-PSI format for molecular interactions. BMC Biol (2007) 8.03
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature (2000) 7.03
Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol (2002) 6.68
Pathguide: a pathway resource list. Nucleic Acids Res (2006) 6.05
A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol (2005) 5.68
LibSBML: an API library for SBML. Bioinformatics (2008) 5.61
GenMAPP 2: new features and resources for pathway analysis. BMC Bioinformatics (2007) 4.97
Executable cell biology. Nat Biotechnol (2007) 4.64
A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat Biotechnol (2008) 4.55
Modelling and analysis of gene regulatory networks. Nat Rev Mol Cell Biol (2008) 4.36
A module of negative feedback regulators defines growth factor signaling. Nat Genet (2007) 4.35
Presenting and exploring biological pathways with PathVisio. BMC Bioinformatics (2008) 4.34
Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem (1999) 4.19
Towards a theory of biological robustness. Mol Syst Biol (2007) 3.82
Key biology databases go wiki. Nature (2007) 3.41
A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov (2007) 3.22
Tools for visually exploring biological networks. Bioinformatics (2007) 3.20
A comprehensive map of the toll-like receptor signaling network. Mol Syst Biol (2006) 2.89
VisANT: an integrative framework for networks in systems biology. Brief Bioinform (2008) 2.85
Big data: Wikiomics. Nature (2008) 2.70
Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses. Mol Syst Biol (2007) 2.56
Tools for kinetic modeling of biochemical networks. Nat Biotechnol (2006) 2.29
Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes (2003) 2.16
Representations of molecular pathways: an evaluation of SBML, PSI MI and BioPAX. Bioinformatics (2005) 1.91
The emerging world of wikis. Science (2008) 1.84
Systems-level interactions between insulin-EGF networks amplify mitogenic signaling. Mol Syst Biol (2009) 1.77
Principles behind the multifarious control of signal transduction. ERK phosphorylation and kinase/phosphatase control. FEBS J (2005) 1.71
BiNoM: a Cytoscape plugin for manipulating and analyzing biological networks. Bioinformatics (2007) 1.65
A comprehensive modular map of molecular interactions in RB/E2F pathway. Mol Syst Biol (2008) 1.61
PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk. Mol Syst Biol (2009) 1.40
Representing, storing and accessing molecular interaction data: a review of models and tools. Brief Bioinform (2006) 1.39
The endothelial glycocalyx: a mechano-sensor and -transducer. Sci Signal (2008) 1.34
The public road to high-quality curated biological pathways. Drug Discov Today (2008) 1.22
Regulation of P2X2 receptors by the neuronal calcium sensor VILIP1. Sci Signal (2008) 1.07
Simulation of crosstalk between small GTPase RhoA and EGFR-ERK signaling pathway via MEKK1. Bioinformatics (2008) 0.89
Signaling networks and mathematics. Sci Signal (2008) 0.86
The Semanticscience Integrated Ontology (SIO) for biomedical research and knowledge discovery. J Biomed Semantics (2014) 1.66
Inroads to predict in vivo toxicology-an introduction to the eTOX Project. Int J Mol Sci (2012) 1.64
DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks. Bioinformatics (2010) 1.54
Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases. PLoS One (2011) 1.51
[Health information on the Internet and trust marks as quality indicators: vaccines case study]. Aten Primaria (2009) 1.49
Assessment of NER solutions against the first and second CALBC Silver Standard Corpus. J Biomed Semantics (2011) 1.43
OSIRIS: a tool for retrieving literature about sequence variants. Bioinformatics (2006) 1.42
A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J Chem Inf Model (2011) 1.38
Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors. J Med Chem (2005) 1.26
Induced effects of sodium ions on dopaminergic G-protein coupled receptors. PLoS Comput Biol (2010) 1.25
The EU-ADR corpus: annotated drugs, diseases, targets, and their relationships. J Biomed Inform (2012) 1.23
OSIRISv1.2: a named entity recognition system for sequence variants of genes in biomedical literature. BMC Bioinformatics (2008) 1.13
Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med (2015) 1.12
From SNPs to pathways: integration of functional effect of sequence variations on models of cell signalling pathways. BMC Bioinformatics (2009) 1.08
Automatic filtering and substantiation of drug safety signals. PLoS Comput Biol (2012) 0.96
The EU-ADR Web Platform: delivering advanced pharmacovigilance tools. Pharmacoepidemiol Drug Saf (2012) 0.95
Challenges in the association of human single nucleotide polymorphism mentions with unique database identifiers. BMC Bioinformatics (2011) 0.94
Knowledge engineering for health: a new discipline required to bridge the "ICT gap" between research and healthcare. Hum Mutat (2012) 0.91
Knowledge environments representing molecular entities for the virtual physiological human. Philos Trans A Math Phys Eng Sci (2008) 0.91
Identifying gene-specific variations in biomedical text. J Bioinform Comput Biol (2007) 0.91
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system. PLoS One (2013) 0.88
Network medicine analysis of COPD multimorbidities. Respir Res (2014) 0.87
Applicability Domain ANalysis (ADAN): a robust method for assessing the reliability of drug property predictions. J Chem Inf Model (2014) 0.85
Multistructure 3D-QSAR studies on a series of conformationally constrained butyrophenones docked into a new homology model of the 5-HT2A receptor. J Med Chem (2007) 0.85
Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands. Bioorg Med Chem Lett (2009) 0.83
QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. Neuropharmacology (2006) 0.83
On the generation of catalytic antibodies by transition state analogues. Chembiochem (2003) 0.82
Novel insights into biased agonism at G protein-coupled receptors and their potential for drug design. Curr Pharm Des (2013) 0.82
Multi-receptor binding profile of clozapine and olanzapine: a structural study based on the new beta2 adrenergic receptor template. ChemMedChem (2008) 0.82
Incorporating molecular shape into the alignment-free Grid-Independent Descriptors. J Med Chem (2004) 0.82
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry. Clin Cancer Res (2013) 0.82
Acrosin antibodies and infertility. I. Detection of antibodies towards proacrosin/acrosin in women consulting for infertility and evaluation of their effects upon the sperm protease activities. Fertil Steril (2008) 0.82
1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor. Bioorg Med Chem (2008) 0.81
Continuing education and community pharmacists in Galicia: a study of opinions. Pharm World Sci (2004) 0.81
A chemocentric approach to the identification of cancer targets. PLoS One (2012) 0.81
Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D(2) and D(3) receptors. ChemMedChem (2010) 0.79
New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones. J Med Chem (2002) 0.79
Use of alignment-free molecular descriptors in diversity analysis and optimal sampling of molecular libraries. Mol Divers (2003) 0.78
Anti-human proacrosin antibody inhibits the zona pellucida (ZP)-induced acrosome reaction of ZP-bound spermatozoa. Fertil Steril (2009) 0.78
The impact of computer science in molecular medicine: enabling high-throughput research. Curr Top Med Chem (2013) 0.77
Discussion of "The New Role of Biomedical Informatics in the Age of Digital Medicine". Methods Inf Med (2016) 0.76
INFOBIOMED: European Network of Excellence on Biomedical Informatics to support individualised healthcare. AMIA Annu Symp Proc (2005) 0.76
A novel multilevel statistical method for the study of the relationships between multireceptorial binding affinity profiles and in vivo endpoints. Mol Pharmacol (2009) 0.76
Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics. J Med Chem (2008) 0.76
Comparative analysis of putative agonist-binding modes in the human A1 adenosine receptor. Chembiochem (2004) 0.76
Conformationally constrained butyrophenones as new pharmacological tools to study 5-HT 2A and 5-HT 2C receptor behaviours. Eur J Med Chem (2003) 0.76
Novel approaches for modeling of the A1 adenosine receptor and its agonist binding site. Proteins (2004) 0.76
Distant collaboration in drug discovery: the LINK3D project. J Comput Aided Mol Des (2002) 0.76
Towards a MIP-based alignment and docking in computer-aided drug design. Proteins (2004) 0.75
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor. J Med Chem (2006) 0.75
[Analysis of knowledge of international criteria for authorship by the Spanish researchers]. Med Clin (Barc) (2009) 0.75
Synthesis, adenosine receptor binding and 3D-QSAR of 4-substituted 2-(2'-furyl)-1,2,4-triazolo[1,5-a]quinoxalines. Bioorg Med Chem (2008) 0.75
[Computer-assisted clinical decision support systems]. Med Clin (Barc) (2004) 0.75
[Assessing the implementation of the VisualCor software in medical practice]. Med Clin (Barc) (2005) 0.75
Influence of pH on the binding of diphenylmethylenepiperidines by 5-HT2B receptors in rat stomach fundus. Chem Pharm Bull (Tokyo) (2002) 0.75
Antiacrosin antibodies and infertility. II. Gene immunization with human proacrosin to assess the effect of immunity toward proacrosin/acrosin upon protein activities and animal fertility. Fertil Steril (2008) 0.75